2023 BSSO 指南:肛管癌治疗

2023-04-06 BSSO Brazilian society of surgical oncology 巴西外科肿瘤学会 J Surg Oncol 发表于安徽省

SBCO 制定了本指南,以根据当前科学证据就与肛管鳞状细胞癌 (SCC) 管理相关的主要主题提供建议。

中文标题:

2023 BSSO 指南:肛管癌治疗

英文标题:

Brazilian Society of Surgical Oncology: Guidelines for the management of anal canal cancer

发布日期:

2023-04-06

简要介绍:

肛管鳞状细胞癌 (SCC) 是一种相对少见的肿瘤,主要是局部区域癌症,转移潜能低(仅 15%),大多数病例通过根治性放化疗可治愈。另一方面,其发病率在过去几十年中一直在稳步上升,这使其成为一个重要的公共卫生问题。为了向治疗肛门癌患者的外科医生和肿瘤学家提供基于最佳科学证据的最新信息,巴西外科肿瘤学会 (SBCO) 制定了目前的肛管 SCC 管理指南,重点是与日常临床实践相关的主要主题。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2023 BSSO 指南:肛管癌治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0b5091c003111ed1, title=2023 BSSO 指南:肛管癌治疗, enTitle=Brazilian Society of Surgical Oncology: Guidelines for the management of anal canal cancer, guiderFrom=J Surg Oncol, authorId=0, author=, summary=SBCO 制定了本指南,以根据当前科学证据就与肛管鳞状细胞癌 (SCC) 管理相关的主要主题提供建议。, cover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, journalId=0, articlesId=null, associationId=3185, associationName=BSSO Brazilian society of surgical oncology 巴西外科肿瘤学会, associationIntro=BSSO Brazilian society of surgical oncology 巴西外科肿瘤学会, copyright=0, guiderPublishedTime=Thu Apr 06 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p><span style="color: #1c1d1e;">肛管鳞状细胞癌 (SCC) 是一种相对少见的肿瘤,主要是局部区域癌症,转移潜能低(仅 15%),大多数病例通过根治性放化疗可治愈。</span><span style="color: #1c1d1e;">另一方面,其发病率在过去几十年中一直在稳步上升,这使其成为一个重要的公共卫生问题。</span><span style="color: #1c1d1e;">为了向治疗肛门癌患者的外科医生和肿瘤学家提供基于最佳科学证据的最新信息,巴西外科肿瘤学会 (SBCO) 制定了目前的肛管 SCC 管理指南,重点是与日常临床实践相关的主要主题。</span></p>, tagList=[TagDto(tagId=61338, tagName=肛管鳞状细胞癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=61338, articleKeyword=肛管鳞状细胞癌, articleKeywordNum=6, guiderKeywordId=61338, guiderKeyword=肛管鳞状细胞癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=7, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7170, appHits=33, showAppHits=0, pcHits=190, showPcHits=7137, likes=1, shares=2, comments=4, approvalStatus=1, publishedTime=Thu Apr 27 12:12:00 CST 2023, publishedTimeString=2023-04-06, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Apr 25 00:16:02 CST 2023, updatedBy=2427819, updatedName=梁丽玲, updatedTime=Thu Jan 04 10:31:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=安徽省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2023 BSSO 指南:肛管癌治疗.pdf)])
2023 BSSO 指南:肛管癌治疗.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2128647, encodeId=33ee212864e87, content=哈哈很不错👌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f9d1693381, createdName=1de62fe8m70(暂无匿称), createdTime=Thu Apr 27 12:57:20 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128643, encodeId=6c64212864378, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJibu7hwJqpmHiaJgLLmJmcwp0WDTxWI3vqPBO1Mloq21VBOPqziapyibYatvd2QWHWicolL1vbVZHgpRQ/132, createdBy=d16a2107341, createdName=JZ Yang, createdTime=Thu Apr 27 12:45:23 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省)]
    2023-04-27 1de62fe8m70(暂无匿称) 来自浙江省

    哈哈很不错👌

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2128647, encodeId=33ee212864e87, content=哈哈很不错👌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f9d1693381, createdName=1de62fe8m70(暂无匿称), createdTime=Thu Apr 27 12:57:20 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2128643, encodeId=6c64212864378, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJibu7hwJqpmHiaJgLLmJmcwp0WDTxWI3vqPBO1Mloq21VBOPqziapyibYatvd2QWHWicolL1vbVZHgpRQ/132, createdBy=d16a2107341, createdName=JZ Yang, createdTime=Thu Apr 27 12:45:23 CST 2023, time=2023-04-27, status=1, ipAttribution=浙江省)]
    2023-04-27 JZ Yang 来自浙江省

    感谢

    0

拓展阅读

JAMA Surg:早期肛管鳞状细胞癌患者治疗方案比较研究——局部切除vs同步放化疗

研究认为对于早期肛管鳞状细胞癌患者,接受局部切除后的生存期非劣于同步放化疗,且手术疗法的成本低,患者痛苦少